患者在急性冠状动脉综合征后对他们的心血管药物的信念:一项前性观察研究
Arden R Barry1,2, Erica H Z Wang1,3, Doson Chua1,3
1Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada.
CJC open
|October 25, 2023
概括
患者对急性冠状动脉综合征 (ACS) 后二次预防药物的信念保持稳定,尽管必要性的信念下降. 监测这些信念对于改善坚持和预防复发性心血管事件至关重要.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 健康心理学 心理健康心理学
背景情况:
- 在急性冠状动脉综合征 (ACS) 后,对二次预防性药物治疗的坚持往往很差,增加了心血管事件的复发风险.
- 患者对药物的信念显著预测了故意的不服药.
研究的目的:
- 通过验证的问卷来评估成年患者对ACS后药物的信念和坚持.
- 为了评估药物信仰和从住院到出院后4周的药物坚持的变化.
- 识别与药物信仰变化相关的因素.
主要方法:
- 在加拿大温哥华圣保罗医院进行前性观察研究 (2022年5月至12月).
- 使用了关于药物的信念问卷 (BMQ) 和药物坚持报告尺度 (MARS-5).
- 在住院期间和4周随访期间使用问卷.
主要成果:
- 47名参与者完成了这项研究;平均年龄64岁,83%是男性;大多数人没有非ST段升高ACS.
- 从出院到4周,整体BMQ需要关注差异 (BMQ-NCD) 或MARS-5得分没有显著变化.
- 观察到BMQ特定需求分量表显著下降 (P=0.002).
- 南亚和中东的种族,兼职工作和男性性别与BMQ-NCD有关.
结论:
- 患者通常对后ACS药物持有有利的信念,必要性的信念略有下降.
- 欧洲血统,兼职工作和男性性别与较低的BMQ-NCD有关.
- 人们注意到自我报告的坚持程度很高;建议对药物必要性信念进行持续评估.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Acute Coronary Syndrome V: Nursing Management
16
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
16
Acute Coronary Syndrome III: Diagnostic Studies
9
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
19
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
19
Angina IV: Management
9
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
9


